Pioneering the better diagnostics, care and treatment, BGSi is established to leapfrog Indonesia into the era of precision medicine

Get to know more about our biosample collection, recruitment and sequencing progress

BGSi coordinates biomedical projects, next generation sequencing machines, and biobank facilities across Indonesia

What Disease Areas that BGSi primarily focuses on?

Infectious Diseases
Aim to identify complex pathogen-host interactions and factors related to multi drug resistance, enabling appropriate and effective treatment
Metabolic Diseases
Promote lifestyle changes based on genomic information to prevent metabolic disorders especially in young population
Cancer
Focus on genome-based service for better screening, diagnosis and long run monitoring of disease to improve survival and quality of life of patients
Brain and Neurodegenerative Diseases
Identify individual's risk score of stroke and applying a pharmacogenomics approach to improve the prevention and treatment outcome
Genetic Disorders
Use genetic testing to uncover key genes related with disease severity young genetic disorders patient, specifically DMD and PAH cases
Aging, Nutrition, and Wellness
Discover main genetic factor related with systemic treatment and comorbidity to increase the disease remission and patients' quality of life
Cardiovascular Diseases
Focus on early diagnosis, appropriate risk stratification, personalized therapy, and a significant reduction in atherosclerotic cardiovascular disease
Maternal, Reproductive and Neonatal
To lower the number of preventable birth defects, increase universal early screening of pregnant woman

3 integrated platforms are provided to support BGSi programmes and services

Biobank
A repository facility that manages the collection, storage, processing and distribution of various types of biological specimens (including DNA, RNA, tumor or non-tumor tissue, cells, blood, plasma, serum, saliva, etc.) and their associated data in a well-organized system. The biological specimens are derived from patients or healthy participants who have given consent to participate in the biobank.
Read more
Registry
A well-structured metadata repository consisting of patient demographic data, clinical data, lifestyle information, and other information derived from the analysis conducted on the samples derived from the patient. This platform is a valuable asset for scientists and clinicians who seek to answer a multitude of questions by exploiting well curated patient specific information.
Read more
Bioinformatics
BGSi provides support in the use of bioinformatic tools for genomic data analysis both at whole genome level and with more sophisticated targeted strategies. The tools are used to analyze sequencing data, gene variation and expression, and other OMICS data generated from either Hubs or Central BGSi.
Read more

Want to know better about BGSi?